Med Oncol. 2017 Aug34(8) 132. doi 10.1007/s12032-017-0991-5. Epub 2017 Jun 26.
Journal of Medical Imaging and Radiation Oncology (formerly Australasian Radiology) is the official journal of The Royal Australian and New Zealand College of Radiologists publishing articles of scientific excellence in radiology and radiation oncology.Manuscripts are judged on the basis of their contribution of original data and ideas or interpretation.
Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality peer reviewed original research (especially reports from clinical trials) reviews comment and opinion weekly news and Commissions (typically in partnership with societies governments NGOs and academy centres).
2021-7-21 · Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer from the more basic discoveries dealing with both cell and molecular biology of tumour cells to the most advanced clinical assays of conventional and new drugs.
2018-3-25 · 2021-06-30 ms3352099995456729. 3.06. MED ONCOL2020 ## 3.064 3 3 . 3 . . 106 0. 2018-03-26 .
The archive for this journal includes Clin Med Insights Oncol Vols. 4 to 15 2010 to 2021 Clin Med Oncol Vols. 2 to 3 2008 to 2009
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
2021-2-27 · Med Oncol. 2002 19(2) 71–8 60. Wumkes ML van der Velden AMT Los M Leys MBL Beeker A Nijziel MR et al. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.
2021-7-17 · Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology.
2019-6-3 · Abstract Background The use of adjuvant chemotherapy in patients with breast cancer may be guided by clinicopathological factors and a score based on
2019-5-28 · The median overall survival among patients receiving pertuzumab trastuzumab and docetaxel (pertuzumab group) was 56.5 months 15.7 months longer than survival among patients receiving placebo
2018-2-14 · Purpose To increase awareness outline strategies and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Methods A multidisciplinary multi-organizational panel of experts in medical oncology dermatology gastroenterology rheumatology pulmonology endocrinology urology neurology
2018-1-31 · N Engl J Med 377 338-351 2017 Crossref Medline Google Scholar 7. Gravis G Fizazi K Joly F et al Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15) A randomised open-label phase 3 trial. Lancet Oncol 14 149-158 2013 Crossref Medline Google Scholar 8.
2019-1-8 · Lancet Oncol 17 1497-1508 2016 Crossref Medline Google Scholar 18. Gandhi L Rodríguez-Abreu D Gadgeel S et al Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378 2078-2092 2018 Crossref Medline Google Scholar 19.
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies Sanmei Wang Leopold Sellner Lei Wang Tim Sauer Brigitte Neuber Wenjie Gong Sophia Stock Ming Ni Hao Yao Christian Kleist Anita Schmitt Carsten Müller‑Tidow Michael Schmitt Maria-Luisa Schubert
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
Indian Journal of Medical and Paediatric Oncology (IJMPO) is a bi-monthly peer-reviewed international journal published by Thieme Medical Publishers on behalf of the Indian Society of Medical and Paediatric Oncology (ISMPO). The journal is available in both print and online versions. We receive more than 500 manuscripts each year and are
2021-6-16 · Non–small-cell lung cancer is a major cause of death from cancer. The use of cytotoxic chemotherapy is associated with a response rate of 20 to 35 and a
2015-6-18 · February 02 2015. Clinicopathologic Characteristics and Management Trends of Cutaneous Invasive and In Situ Melanoma in Older Patients. The incidence of melanoma in
Latest Impact Factor announced. The latest Impact Factor for Neuro-Oncology has risen to 10.247. To celebrate we have curated a selection of highly cited articles contributing to the new Impact Factor and invite you to explore this collection. Read the collection. Advertisement.
2018-4-16 · Inhibitors of programmed death 1 (PD-1) and its ligand PD-L1 are effective therapies for metastatic non–small-cell lung cancer (NSCLC) lacking sensitizing EGFR or ALK mutations. Pembrolizumab
Latest Impact Factor announced. The latest Impact Factor for Neuro-Oncology has risen to 10.247. To celebrate we have curated a selection of highly cited articles contributing to the new Impact Factor and invite you to explore this collection. Read the collection. Advertisement.
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies Sanmei Wang Leopold Sellner Lei Wang Tim Sauer Brigitte Neuber Wenjie Gong Sophia Stock Ming Ni Hao Yao Christian Kleist Anita Schmitt Carsten Müller‑Tidow Michael Schmitt Maria-Luisa Schubert
2015-6-18 · February 02 2015. Clinicopathologic Characteristics and Management Trends of Cutaneous Invasive and In Situ Melanoma in Older Patients. The incidence of melanoma in
2017-6-1 · Journal of medical imaging and radiation oncology (ISSN 1754-9477 1754-9485)
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
The archive for this journal includes Clin Med Insights Oncol Vols. 4 to 15 2010 to 2021 Clin Med Oncol Vols. 2 to 3 2008 to 2009
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies Sanmei Wang Leopold Sellner Lei Wang Tim Sauer Brigitte Neuber Wenjie Gong Sophia Stock Ming Ni Hao Yao Christian Kleist Anita Schmitt Carsten Müller‑Tidow Michael Schmitt Maria-Luisa Schubert
Journal of Medical Imaging and Radiation Oncology (formerly Australasian Radiology) is the official journal of The Royal Australian and New Zealand College of Radiologists publishing articles of scientific excellence in radiology and radiation oncology.Manuscripts are judged on the basis of their contribution of original data and ideas or interpretation.
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
2021-2-27 · Med Oncol. 2002 19(2) 71–8 60. Wumkes ML van der Velden AMT Los M Leys MBL Beeker A Nijziel MR et al. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.
2021-7-22 · Journal updates. The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal which is chiefly devoted to Original papers also includes Reviews as well as Editorials and Guest editorials on current controversial topics.
Main focuses of interest include Annals of Oncology the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology provides rapid and efficient peer-review publications on innovative cancer treatments or translational work
2018-4-16 · Inhibitors of programmed death 1 (PD-1) and its ligand PD-L1 are effective therapies for metastatic non–small-cell lung cancer (NSCLC) lacking sensitizing EGFR or ALK mutations. Pembrolizumab
Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications
2017-4-19 · Semin Oncol. 201542 495–505. Article PubMed Google Scholar 4. Le DT Uram JN Wang H Bartlett BR Kemberling H Eyring AD et al. PD-1 Blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015372 2509–20. CAS Article PubMed PubMed Central Google Scholar 5.
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
